Short Interest in Medios AG (OTCMKTS:MEDOF) Declines By 42.8%

Medios AG (OTCMKTS:MEDOF) was the target of a large decline in short interest in May. As of May 15th, there was short interest totaling 1,924 shares, a decline of 42.8% from the April 30th total of 3,361 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is presently ? days.

Medios Stock Performance

MEDOF stock remained flat at C$13.64 during midday trading on Tuesday. Medios has a one year low of C$13.64 and a one year high of C$13.64. The stock has a fifty day moving average price of C$13.64 and a 200 day moving average price of C$13.64.

Medios Company Profile

Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment includes cytostatic infusion preparations, antibody therapies, virostatic and antibiotic medications, parenteral nutrition solutions, and investigational medicinal products.